Published in Int J Cancer on March 16, 2013
Genital inflammation and the risk of HIV acquisition in women. Clin Infect Dis (2015) 1.31
Link between chronic inflammation and human papillomavirus-induced carcinogenesis (Review). Oncol Lett (2015) 0.90
Maternal cadmium, iron and zinc levels, DNA methylation and birth weight. BMC Pharmacol Toxicol (2015) 0.85
Current therapeutic vaccination and immunotherapy strategies for HPV-related diseases. Hum Vaccin Immunother (2016) 0.82
Effect of human papillomavirus infection on the immune system and its role in the course of cervical cancer. Oncol Lett (2015) 0.79
The Role of Chlamydia trachomatis in High-Risk Human Papillomavirus Persistence Among Female Sex Workers in Nairobi, Kenya. Sex Transm Dis (2015) 0.78
Early Defensive Mechanisms against Human Papillomavirus Infection. Clin Vaccine Immunol (2015) 0.78
Cytokine profile in cervical mucosa of Japanese patients with cervical intraepithelial neoplasia. Int J Clin Oncol (2014) 0.76
IL-10, IL-15, IL-17, and GMCSF levels in cervical cancer tissue of Tanzanian women infected with HPV16/18 vs. non-HPV16/18 genotypes. Infect Agent Cancer (2015) 0.75
Association of serum cytokines with oral HPV clearance. Cytokine (2016) 0.75
The Effect of Intrauterine Devices on Acquisition and Clearance of Human Papillomavirus. Am J Obstet Gynecol (2016) 0.75
Diversity of Cervicovaginal Cytokine Response to Incident Chlamydia trachomatis Infection Among a Prospective Cohort of Young Women. Am J Reprod Immunol (2015) 0.75
Inflammation and cancer: back to Virchow? Lancet (2001) 27.40
Pattern recognition receptors and inflammation. Cell (2010) 21.05
The impact of confounder selection criteria on effect estimation. Am J Epidemiol (1989) 13.34
Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest (1998) 13.05
Human papillomavirus and cervical cancer. Lancet (2007) 12.47
Improved amplification of genital human papillomaviruses. J Clin Microbiol (2000) 11.50
Resolution of inflammation: the beginning programs the end. Nat Immunol (2005) 9.81
Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method. J Clin Microbiol (1998) 9.43
Immunosuppressive effects of apoptotic cells. Nature (1997) 7.03
IL-10: the master regulator of immunity to infection. J Immunol (2008) 6.11
Phosphatidylserine-dependent ingestion of apoptotic cells promotes TGF-beta1 secretion and the resolution of inflammation. J Clin Invest (2002) 5.55
A proinflammatory cytokine inhibits p53 tumor suppressor activity. J Exp Med (1999) 4.15
The natural history of human papillomavirus infection as measured by repeated DNA testing in adolescent and young women. J Pediatr (1998) 3.96
A note on the use of the intraclass correlation coefficient in the evaluation of agreement between two methods of measurement. Comput Biol Med (1990) 3.18
Herpes simplex virus-2 as a human papillomavirus cofactor in the etiology of invasive cervical cancer. J Natl Cancer Inst (2002) 2.75
Cytokines in acute and chronic inflammation. Front Biosci (1997) 2.67
Immunological events in regressing genital warts. Am J Clin Pathol (1994) 2.37
Immune responses to human papillomavirus. Vaccine (2006) 2.37
Chronic immune activation and inflammation as the cause of malignancy. Br J Cancer (2001) 2.26
Persistence of human papillomavirus infection: keys to malignant progression. Trends Microbiol (2010) 1.96
Immune evasion in human papillomavirus-associated cervical cancer. Nat Rev Cancer (2002) 1.92
Activation of host pattern recognition receptors by viruses. Curr Opin Microbiol (2010) 1.73
Prevalence, acquisition, and clearance of cervical human papillomavirus infection among women with normal cytology: Hawaii Human Papillomavirus Cohort Study. Cancer Res (2008) 1.73
Cell-mediated immune response to human papillomavirus infection. Clin Diagn Lab Immunol (2001) 1.61
HPV - immune response to infection and vaccination. Infect Agent Cancer (2010) 1.48
Evolving immunosuppressive microenvironment during human cervical carcinogenesis. Mucosal Immunol (2008) 1.44
Apoptotic cells and innate immune stimuli combine to regulate macrophage cytokine secretion. J Immunol (2003) 1.43
The relationship between angiogenesis and the immune response in carcinogenesis and the progression of malignant disease. Eur J Cancer (2000) 1.43
Cytokine and immunoglobulin concentrations in cervical secretions: reproducibility of the Weck-cel collection instrument and correlates of immune measures. J Immunol Methods (1999) 1.34
Evidence for Chlamydia trachomatis as a human papillomavirus cofactor in the etiology of invasive cervical cancer in Brazil and the Philippines. J Infect Dis (2002) 1.32
Clinician's guide to human papillomavirus immunology: knowns and unknowns. Lancet Infect Dis (2009) 1.29
Performance of swabs, lavage, and diluents to quantify biomarkers of female genital tract soluble mucosal mediators. PLoS One (2011) 1.28
Characterization of immunoglobulins and cytokines in human cervical mucus: influence of exogenous and endogenous hormones. J Reprod Immunol (1999) 1.27
Human papillomavirus deregulates the response of a cellular network comprising of chemotactic and proinflammatory genes. PLoS One (2011) 1.26
The evolving definition of carcinogenic human papillomavirus. Infect Agent Cancer (2009) 1.23
Determination of cytokine protein levels in cervical mucus samples from young women by a multiplex immunoassay method and assessment of correlates. Clin Vaccine Immunol (2007) 1.22
Association between toll-like receptor expression and human papillomavirus type 16 persistence. Int J Cancer (2011) 1.17
High-risk human papillomaviruses repress constitutive kappa interferon transcription via E6 to prevent pathogen recognition receptor and antiviral-gene expression. J Virol (2011) 1.16
Are genital infections and inflammation cofactors in the pathogenesis of invasive cervical cancer? J Natl Cancer Inst (2002) 1.16
Higher levels of cervicovaginal inflammatory and regulatory cytokines and chemokines in healthy young women with immature cervical epithelium. J Reprod Immunol (2010) 1.07
The role of inflammation in HPV carcinogenesis. Carcinogenesis (2010) 1.07
Regulation of immune responses to HPV infection and during HPV-directed immunotherapy. Immunol Rev (2011) 1.05
Interlaboratory reproducibility of female genital tract cytokine measurements by Luminex: implications for microbicide safety studies. Cytokine (2011) 1.05
Differences in the concentration and correlation of cervical immune markers among HPV positive and negative perimenopausal women. Cytokine (2011) 1.04
Innate immunity at the mucosal surface: role of toll-like receptor 3 and toll-like receptor 9 in cervical epithelial cell responses to microbial pathogens. Biol Reprod (2006) 1.03
Papanicolaou smears and cervical inflammatory cytokine responses. J Inflamm (Lond) (2007) 0.89
Slumbering mucosal immune response in the cervix of human papillomavirus DNA-positive and -negative women. Int J Oncol (2010) 0.85
Genital epithelial cells: foot soldiers or fashion leaders? J Leukoc Biol (2010) 0.80
Inflammatory response in cervical intraepithelial neoplasia and squamous cell carcinoma of the uterine cervix. Pathol Res Pract (1997) 0.78
Human papillomavirus and rising oropharyngeal cancer incidence in the United States. J Clin Oncol (2011) 12.10
Sustained efficacy up to 4.5 years of a bivalent L1 virus-like particle vaccine against human papillomavirus types 16 and 18: follow-up from a randomised control trial. Lancet (2006) 7.83
Ethnic and racial differences in the smoking-related risk of lung cancer. N Engl J Med (2006) 7.82
Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition Study. J Natl Cancer Inst (2006) 6.41
Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case-control studies. Lancet Oncol (2012) 5.70
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. CA Cancer J Clin (2012) 5.58
American Cancer Society guideline for the early detection of cervical neoplasia and cancer. CA Cancer J Clin (2002) 5.56
Spectrum of cancer risk among US solid organ transplant recipients. JAMA (2011) 4.99
Impact of socioeconomic status on cancer incidence and stage at diagnosis: selected findings from the surveillance, epidemiology, and end results: National Longitudinal Mortality Study. Cancer Causes Control (2008) 4.56
Common variants at 19p13 are associated with susceptibility to ovarian cancer. Nat Genet (2010) 4.51
A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2. Nat Genet (2009) 4.38
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet (2013) 4.35
A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. Nat Genet (2010) 3.86
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. Am J Clin Pathol (2012) 3.51
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nat Genet (2013) 3.42
Consistent association of type 2 diabetes risk variants found in europeans in diverse racial and ethnic groups. PLoS Genet (2010) 3.27
Barriers to HAART adherence among human immunodeficiency virus-infected adolescents. Arch Pediatr Adolesc Med (2003) 3.26
American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer. J Low Genit Tract Dis (2012) 3.15
Lung cancer occurrence in never-smokers: an analysis of 13 cohorts and 22 cancer registry studies. PLoS Med (2008) 2.90
American Cancer Society Guideline for human papillomavirus (HPV) vaccine use to prevent cervical cancer and its precursors. CA Cancer J Clin (2007) 2.81
Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study. Lancet Oncol (2013) 2.48
A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. Hum Mol Genet (2012) 2.45
Breast cancer in a multiethnic cohort in Hawaii and Los Angeles: risk factor-adjusted incidence in Japanese equals and in Hawaiians exceeds that in whites. Cancer Epidemiol Biomarkers Prev (2002) 2.45
Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association Consortium. J Natl Cancer Inst (2014) 2.40
A review of the research literature on evidence-based healthcare design. HERD (2008) 2.36
Quality of race, Hispanic ethnicity, and immigrant status in population-based cancer registry data: implications for health disparity studies. Cancer Causes Control (2007) 2.36
Factors associated with dietary supplement use among healthy adults of five ethnicities: the Multiethnic Cohort Study. Am J Epidemiol (2003) 2.30
Heterozygous mutations of OTX2 cause severe ocular malformations. Am J Hum Genet (2005) 2.26
Breast cancer risk factors defined by estrogen and progesterone receptor status: the multiethnic cohort study. Am J Epidemiol (2009) 2.14
Genetic determinants of lipid traits in diverse populations from the population architecture using genomics and epidemiology (PAGE) study. PLoS Genet (2011) 2.13
Anal human papillomavirus infection in women and its relationship with cervical infection. Cancer Epidemiol Biomarkers Prev (2005) 2.11
Duration and clearance of anal human papillomavirus (HPV) infection among women: the Hawaii HPV cohort study. Clin Infect Dis (2009) 2.10
Patterns of leukemia incidence in the United States by subtype and demographic characteristics, 1997-2002. Cancer Causes Control (2007) 2.09
The role of KRAS rs61764370 in invasive epithelial ovarian cancer: implications for clinical testing. Clin Cancer Res (2011) 2.09
External genital warts: diagnosis, treatment, and prevention. Clin Infect Dis (2002) 2.05
Understanding the burden of human papillomavirus-associated anal cancers in the US. Cancer (2008) 2.03
Infertility, fertility drugs, and ovarian cancer: a pooled analysis of case-control studies. Am J Epidemiol (2002) 2.02
Type I and II endometrial cancers: have they different risk factors? J Clin Oncol (2013) 2.01
Photoreceptors of Nrl -/- mice coexpress functional S- and M-cone opsins having distinct inactivation mechanisms. J Gen Physiol (2005) 1.99
Circulating 25-hydroxyvitamin D and the risk of rarer cancers: Design and methods of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers. Am J Epidemiol (2010) 1.95
Dietary patterns using the Food Guide Pyramid groups are associated with sociodemographic and lifestyle factors: the multiethnic cohort study. J Nutr (2005) 1.94
Rb regulates proliferation and rod photoreceptor development in the mouse retina. Nat Genet (2004) 1.94
Transmission of human papillomavirus in heterosexual couples. Emerg Infect Dis (2008) 1.93
Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancer. Cancer Res (2007) 1.92
Tissues from population-based cancer registries: a novel approach to increasing research potential. Hum Pathol (2005) 1.92
Cancer incidence trends among Asian American populations in the United States, 1990-2008. J Natl Cancer Inst (2013) 1.90
Factors that influence the rate of epithelial maturation in the cervix in healthy young women. J Adolesc Health (2009) 1.89
Mammographic density and breast cancer risk: the multiethnic cohort study. Am J Epidemiol (2005) 1.86
Dietary variety increases the probability of nutrient adequacy among adults. J Nutr (2004) 1.82
A prospective examination of weight gain in hospitalized adolescents with anorexia nervosa on a recommended refeeding protocol. J Adolesc Health (2011) 1.74
Prevalence, acquisition, and clearance of cervical human papillomavirus infection among women with normal cytology: Hawaii Human Papillomavirus Cohort Study. Cancer Res (2008) 1.73
Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. Nat Commun (2013) 1.73
CK20 and CK7 protein expression in colorectal cancer: demonstration of the utility of a population-based tissue microarray. Hum Pathol (2005) 1.72
Smoking-related cue-induced brain activation in adolescent light smokers. J Adolesc Health (2011) 1.72
Plasma processing conditions substantially influence circulating microRNA biomarker levels. PLoS One (2013) 1.71
Flavonols and pancreatic cancer risk: the multiethnic cohort study. Am J Epidemiol (2007) 1.69
Behavioral health risks in perinatally HIV-exposed youth: co-occurrence of sexual and drug use behavior, mental health problems, and nonadherence to antiretroviral treatment. AIDS Patient Care STDS (2011) 1.66
Updating the natural history of human papillomavirus and anogenital cancers. Vaccine (2012) 1.65
Meat and fat intake as risk factors for pancreatic cancer: the multiethnic cohort study. J Natl Cancer Inst (2005) 1.65
Imaging memory in temporal lobe epilepsy: predicting the effects of temporal lobe resection. Brain (2010) 1.63
Liquid chromatographic-photodiode array mass spectrometric analysis of dietary phytoestrogens from human urine and blood. J Chromatogr B Analyt Technol Biomed Life Sci (2002) 1.62
Oral contraceptive use, reproductive history, and risk of epithelial ovarian cancer in women with and without endometriosis. Am J Obstet Gynecol (2004) 1.62
ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: a comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome Atlas. Gynecol Oncol (2013) 1.61
Circulating fatty acids and prostate cancer risk in a nested case-control study: the Multiethnic Cohort. Cancer Causes Control (2008) 1.60
Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer. Cancer Res (2009) 1.59
The role of the Wada test in the surgical treatment of temporal lobe epilepsy: an international survey. Epilepsia (2008) 1.58
Using qualitative research to inform survey development on nicotine dependence among adolescents. Drug Alcohol Depend (2002) 1.55